跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ambroxol hydrochloride + clenbuterol hydrochloride
首页
药物
ambroxol hydrochloride + clenbuterol hydrochloride
ambroxol hydrochloride + clenbuterol hydrochloride
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Sustained release preparation containing ambroxol hydrochloride and clenbuterol hydrochloride, and preparation method thereof
申请人: INST PHARM & TOXICOLOGY AMMS
优先权: 2011
CN
Compound ambroxol dripping pill
申请人: ZHENGDA LUZHOU MED SCIENCE
优先权: 2004
CN
Ambroxol hydrochloride atomized inhalation solution and preparation method thereof
申请人: JIANMIN PHARMACEUTICAL GROUPS CORP LTD
优先权: 2018
CN
Preparation method of inhalation solution for treating respiratory diseases
申请人: NANJING JIACHEN PHARMACEUTICAL TECH CO LTD
优先权: 2020
CN
Compound ambroxol sustained-release drop pills and preparation method thereof
申请人: CHIA TAI GREEN CONTINENT PHARM
优先权: 2008
CN
Suspension drop as well as preparation method and application thereof
申请人: HUAJI INT BIOTECHNOLOGY GUANGDONG CO LTD
优先权: 2021
CN
Ambroxterol liquid preparation and preparation method thereof
申请人: CHENGDU BRILLIANT PHARMACEUTICAL CO LTD
优先权: 2021
CN
Compound preparation for treating cough, excessive phlegm and wheeze, and preparation method thereof
申请人: CUI GUANGHUA
优先权: 2021
CN
药物
反馈
